AHG vs PAHC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AHG's Piotroski F-Score of 5/9 indicates a stable but not strong financial position, with significant red flags in profitability and cash flow. The company reports a 0.00% profit margin, negative ROE of -68.29%, and a gross margin of just 1.00%, signaling deep operational inefficiencies. Despite a low debt/equity ratio and decent liquidity, the absence of positive earnings, free cash flow, and a lack of dividend support undermine long-term sustainability. The stock's price performance is driven by speculative momentum rather than fundamentals, with a Price/Sales of 144.30 far exceeding sector averages and no intrinsic value support.
PAHC exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an impressive ROE of 31.80%, indicating efficient operational management. While the stock trades at a significant premium to its Graham Number ($20.42), it remains below its growth-based intrinsic value of $66.67. However, the bullish fundamental outlook is heavily countered by aggressive insider selling from the CEO and a very bearish technical trend (10/100). The company is in a high-growth phase with strong EPS beats, but the divergence between financial health and insider sentiment warrants a neutral stance.
Compare Another Pair
Related Comparisons
AHG vs PAHC: Head-to-Head Comparison
This page compares Akso Health Group (AHG) and Phibro Animal Health Corporation (PAHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.